##plugins.themes.academic_pro.article.sidebar##
Main Article Content
Abstract
Background : Based on WHO data, Covid-19 has officially been declared a pandemic because its spread has reached more than 100 infected countries. Several risk factors can affect the severity of Covid-19 patients, one of which is comorbid obesity. The Covid-19 pandemic occurred when the prevalence of overweight/obesity was increasing in almost every country in the world. Chronic inflammation associated with obesity, impaired immune function, and increased expression of ACE 2 contribute to disease severity and worsen clinical outcomes in obese patients with Covid-19 infection.
Aim : This study aims to analyse the effect of obesity on the severity of the second wave of Covid-19 patients who were hospitalized at RSUD dr. Saiful Anwar Malang.
Methods : This research is an analytic observational study with cross sectional approach. The sample consisted of 46 Covid-19 patients with obesity who were hospitalized at RSUD dr. Saiful Anwar Malng. The data acquired will be analysed using Mann Whitney non-parametric analysis test.
Results : In the obese and non-pbese groups, the p-value was 0,042 and the odds ratio was 1,23. In the distribution of age and sex groups, each group obtained a p-value of 0,363 and 0,592.
Conclusion : There is a significant difference in obesity among patients, with a 1,23-fold increased risk of experiencing severity compared to those who are not obese. Meanwhile, for the distribution based on age and sex, there was no significant difference, but it tended to have a more critical degree of severity towards men and older age.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. WHO. Obesity [Internet]. World Health Organization. 2021 [cited 2021 Sep 22]. Available from: https://www.who.int/health-topics/obesity
2. CNN Indonesia. Satgas Sebut Indonesia Masuk Gelombang Kedua Covid [Internet]. 2021 [cited 2021 Sep 27]. Available from: https://www.cnnindonesia.com/nasional/20210630080610-20-661120/satgas-sebut-indonesia-masuk-gelombang-kedua-Covid-19
3. Adimara A, Prahasanti K, Airlangga MP. Pengaruh Peningkatan Jaringan Adiposa Pada Pasien Obesitas Terhadap Tingkat Keparahan Pasien Covid-19. J Ilm Kedokt Wijaya Kusuma. 2021;10(2):222–42.
4. WHO. Obesity and Overweight. 2020.
5. Riskesdas Kemenkes. Hasil Utama Riset Kesehatan Dasar (Riskesdas). J Phys A Math Theor. 2018;44(8):1–200.
6. CNBC Indonesia. Obesitas Picu Tingginya Kasus Kematian Akibat Covid19 [Internet]. 2021 [cited 2021 Oct 25]. Available from: https://www.cnbcindonesia.com/lifestyle/2%0A0210306193939-33-228340/ obesitaspicu-tingginya-kasus-kematian-akibatcovid-19
7. Mohammad S, Aziz R, Al Mahri S, Malik SS, Haji E, Khan AH, et al. Obesity and Covid-19 : What Makes Obese Host So Vulnerable? Immun Ageing. 2021;18(1):1–10.
8. Rojas-Osornio SA, Cruz-Hernández TR, Drago-Serrano ME, Campos-Rodríguez R. Immunity to Influenza: Impact of Obesity. Obes Res Clin Pract [Internet]. 2019;13(5):419–29. Available from: https://doi.org/10.1016/j.orcp.2019.05.003
9. Honce R, Schultz-Cherry S. Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution. Front Immunol. 2019;10:1071.
10. Petrilli CM, Jones SA, Yang J, Harish R, O’Donnell L, Chernyak Y, et al. Factors Associated with Hospitalization and Critical Illness Among 4,103 Patients with Covid-19 Disease in New York City. Medrxiv. 2020;
11. Zheng KI, Gao F, Wang XB, Sun QF, Pan KH, Wang TY, et al. . Obesity as Risk Factor for Greater Severity of Covid-19 in Patients with Metabolic Associated Fatty Liver Disease. Metab Exp. 2020;108:154244.
12. Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. Severe Obesity, Increasing Age, and Male Sex are Independently Associated with Worse In-Hospital Outcomes, and Higher In-Hospital Mortality, in A Cohort of Patients with Covid-19 in The Bronx, New York. Metabolism [Internet]. 2020;108:154262. Available from: https://doi.org/10.1016/j.metabol.2020.154262
13. Barker H, Parkkila S. Bioinformatic Characterization of AngiotensinConverting Enzyme 2, The Entry Receptor for SARS-CoV-2. PLoS One [Internet]. 2020;15(10):e0240647. Available from: http://dx.doi.org/10.1371/journal.pone.0240647
14. Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-Cell RNA Expression Profiling of ACE 2, The Putative Receptor of Wuhan 2019-Ncov. Biorxiv. 2020;
15. Gheware A, Ray A, Rana D, Bajpai P, Nambirajan A, Arulselvi S, et al. ACE 2 Protein Expression in Lung Tissues of Severe Covid-19 Infection. Sci Rep [Internet]. 2022;12(1):1–10. Available from: https://doi.org/10.1038/s41598-022-07918-6
16. Timuda, C.E., Djajalaksana, S. S, J.JR, Wardoyo, A. Y. P., dan Sutanto H. Analysis of Results of Volatile Organic Compound (VOC) Measurements Using Breathanalyzer On Covid-19 Confirmed Patients With Pneumonia and Without Pneumonia. . Int J Heal Sci. 2022;6(S9):3899–910.
17. Lindgren M, Toska T, Alex C, Lundberg CE, Cronie O, Rosengren A, et al. BMI, Sex, and Outcomes in Hospitalised Patients in Western Sweden During The Covid-19 Pandemic. Sci Rep [Internet]. 2022;12(1):1–9. Available from: https://doi.org/10.1038/s41598-022-09027-w
18. Kwok S, Adam S, Ho JH, Iqbal Z, Turkington P, Razvi S, et al. Obesity: A Critical Risk Factor in The Covid-19 Pandemic. Clin Obes. 2020;10(6):e12403.
19. Goodman KE, Magder LS, Baghdadi JD, Pineles L, Levine AR, Perencevich EN, et al. Impact of Sex and Metabolic Comorbidities on Coronavirus Disease 2019 (Covid-19) Mortality Risk Across Age Groups; 66 646 Inpatients Across 613 US Hospitals. Clin Infect Dis. 2021;73(11):e4113–23.
20. Perrotta F, Corbi G, Mazzeo G, Boccia M, Aronne L, D’Agnano V, et al. Covid-19 and The Elderly: Insights Into Pathogenesis and Clinical Decision-Making. Aging Clin Exp Res [Internet]. 2020;32(8):1599–608. Available from: https://doi.org/10.1007/s40520-020-01631-y
21. Mauvais-Jarvis F. Aging, Male Sex, Obesity, and Metabolic Inflammation Create The Perfect Storm for Covid-19. Diabetes. 2020;69(9):1857–63.